The significance of excessive supraventricular ectopic activity immediately after catheter ablation in the risk stratification for late recurrence of atrial fibrillation

Back

ESC Professional Premium Access

The significance of excessive supraventricular ectopic activity immediately after catheter ablation in the risk stratification for late recurrence of atrial fibrillation

Session: Risks and screening for atrial fibrillation

Topic: Catheter Ablation of Arrhythmias

Speaker: Doctor T. Fujisawa (Toon, JP)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Tomoki Fujisawa

Ehime University, Toon (Japan)

0 follower

6 more presentations in this session

Factors for incorrect automated atrial fibrillation identification in large-scale screening

Speaker: Doctor M. Zink (Aachen, DE)

Impact of CHA2DS2-VASc score on smartphone-based screening for atrial fibrillation: A pre-specified subgroup analysis of the eBRAVE-AF trial

Speaker: Doctor L. Freyer (Munich, DE)

Diagnostic accuracy of handheld single-lead electrocardiographic devices to detect atrial fibrillation: an examination using more than 30,000 rhythm traces in a randomised control trial.

Speaker: Doctor K. Wong (Sydney, AU)

A polygenic risk score predicts atrial fibrillation in patients with coronary artery disease without severe systolic dysfunction.

Speaker: Doctor R. Sandhu (Los Angeles, US)

Incidentally induced atrial fibrillation during programmed electrical stimulation in patients with depressed left ventricular systolic function after an acute myocardial infarction: a CARISMA substudy

Speaker: Doctor T. Sakthivel (Copenhagen, DK)

Access the full session

Risks and screening for atrial fibrillation

Speakers: Doctor T. Fujisawa, Doctor M. Zink, Doctor L. Freyer, Doctor K. Wong, Doctor R. Sandhu...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

The significance of excessive supraventricular ectopic activity immediately after catheter ablation in the risk stratification for late recurrence of atrial fibrillation

About the speaker

Doctor Tomoki Fujisawa

6 more presentations in this session

Factors for incorrect automated atrial fibrillation identification in large-scale screening

Impact of CHA2DS2-VASc score on smartphone-based screening for atrial fibrillation: A pre-specified subgroup analysis of the eBRAVE-AF trial

Diagnostic accuracy of handheld single-lead electrocardiographic devices to detect atrial fibrillation: an examination using more than 30,000 rhythm traces in a randomised control trial.

A polygenic risk score predicts atrial fibrillation in patients with coronary artery disease without severe systolic dysfunction.

Incidentally induced atrial fibrillation during programmed electrical stimulation in patients with depressed left ventricular systolic function after an acute myocardial infarction: a CARISMA substudy

Access the full session

Risks and screening for atrial fibrillation

About the event

ESC Congress 2023

ESC 365 is supported by